Ubs Asset Management Americas Inc Merck & Co., Inc. Transaction History

Ubs Asset Management Americas Inc

$277 Billion
Q1 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 12,547,370 shares of MRK stock, worth $1.55 Billion. This represents 0.6% of its overall portfolio holdings.

Number of Shares

12,547,370

Previous 12,669,967 0.97%

Holding current value

$1.55 Billion

Previous $1.38 Billion 19.86%

% of portfolio

0.6%

Previous 0.55%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $13.9 Million - $16.2 Million	-122,597 Reduced 0.97%	12,547,370 $1.66 Billion
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $1.79 Million - $1.95 Million	17,903 Added 0.14%	12,669,967 $1.38 Billion
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $76.8 Million - $85.3 Million	746,357 Added 6.27%	12,652,064 $1.3 Billion
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $33.1 Million - $37 Million	-322,004 Reduced 2.63%	11,905,707 $1.27 Billion
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $5.68 Million - $7.28 Million	64,902 Added 0.53%	12,227,711 $1.36 Billion

Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $22.4 Million - $25.2 Million	265,432 Added 2.23%	12,162,809 $1.05 Billion
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $1.35 Million - $1.53 Million	16,184 Added 0.14%	11,897,377 $1.08 Billion
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $19 Million - $21.3 Million	-258,147 Reduced 2.13%	11,881,193 $975 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $40.4 Million - $50.6 Million	-559,316 Reduced 4.4%	12,139,340 $930 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $76.7 Million - $84.3 Million	1,069,797 Added 9.2%	12,698,656 $954 Million
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $44.5 Million - $49.2 Million	-632,801 Reduced 5.16%	11,628,859 $904 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $7.97 Million - $9.39 Million	115,757 Added 0.95%	12,261,660 $902 Million
Q4 2020 Mar 01, 2021	SELL	$71.77 - $79.65 $24.8 Million - $27.5 Million	-345,745 Reduced 2.77%	12,145,903 $948 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $22.5 Million - $25.5 Million	308,003 Added 2.53%	12,491,648 $989 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $133 Million - $151 Million	-1,884,504 Reduced 13.4%	12,183,645 $899 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $29.6 Million - $41.1 Million	467,891 Added 3.44%	14,068,149 $1.03 Billion
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $14.8 Million - $16.8 Million	191,393 Added 1.43%	13,600,258 $1.18 Billion
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $133 Million - $145 Million	1,747,453 Added 14.98%	13,408,865 $1.08 Billion
Q2 2019 Aug 15, 2019	BUY	$69.84 - $81.59 $138 Million - $161 Million	1,972,587 Added 20.36%	11,661,412 $0
Q1 2019 May 14, 2019	BUY	$69.58 - $79.36 $31.3 Million - $35.7 Million	450,145 Added 4.87%	9,688,825 $0
Q4 2018 Feb 13, 2019	BUY	$65.24 - $75.71 $12.2 Million - $14.2 Million	187,361 Added 2.07%	9,238,680 $674 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $5.26 Million - $6.19 Million	-91,245 Reduced 1.0%	9,051,319 $0
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $55,353 - $65,035	1,089 Added 0.01%	9,142,564 $0
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $48.3 Million - $56.1 Million	947,112 Added 11.56%	9,141,475 $0
Q4 2017 Feb 09, 2018	SELL	$51.62 - $61.64 $41.4 Million - $49.4 Million	-802,053 Reduced 8.92%	8,194,363 $0
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $528 Million - $568 Million	8,996,416	8,996,416 $0

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Merck & Co., Inc. Transaction History